東北製藥(000597.SZ):方大鋼鐵及一致行動人持股達57.88% 觸及全面要約
格隆匯8月22日丨東北製藥(000597.SZ)公佈,東藥集團、盛京金控集團於2021年6月在瀋陽聯合產權交易所公開徵集其持有的東北製藥全部股份受讓方,轉讓的股份爲2.55億股,佔東北製藥總股本的18.91%(東藥集團轉讓所持東北製藥股份2.11億股,佔東北製藥總股本的15.64%;盛京金控集團轉讓所持東北製藥股份4402.70萬股,佔東北製藥總股本的3.27%)。2021年7月3日,方大鋼鐵成爲股份最終受讓方,並於2021年7月4日與東藥集團、盛京金控集團簽署了股份轉讓協議。
此次轉讓前,方大鋼鐵及其一致行動人已合計持有上市公司5.25億股股份,佔上市公司股份總數的38.97%,持股比例超過30%。此次轉讓完成後,方大鋼鐵及其一致行動人合計持有上市公司7.80億股股份,佔上市公司股份總數的57.88%。
此次要約收購系方大鋼鐵向東北製藥除方大鋼鐵及其一致行動人、東藥集團、盛京金控集團以外的其他股東發出的全面要約收購。此次要約收購價格爲4.93元/股。若上市公司在要約收購報告書摘要公告日至要約收購期限屆滿日期間有派息、送股、資本公積轉增股本等除權除息事項,則要約價格及要約收購股份數量將進行相應的調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.